Cannabis
Khiron Secures Exclusive Endorsement from The Colombian Association of Gerontology and Geriatrics
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that it has entered into an exclusive endorsement agreement with the Colombian Association of Gerontology and Geriatrics (“CAGG”), a scientific and professional association dedicated to the advancement of health and social services for aging populations and geriatric patients at all levels of care.
The endorsement agreement with CAGG will see the Khiron medical leadership team present at the Association’s annual medical congress as part of a year-long exclusive agreement that also includes outreach programs with health care professionals focused on seniors’ care. These activities further extend the Company’s access to leading doctors and health practitioners in the areas of Gerontology, Geriatrics, Internal Medicine, Orthopedics and General Practice.
According to a May 2019 study by the University of Colorado, cannabis use among older adults in the U.S. is growing faster than any other user group, with particular application for the treatment of pain, depression and anxiety. The study indicates barriers including access to cannabis, lack of communications with doctors and lingering stigma. Further, in Colombia alone more than 1 million patients are elderly and suffer from chronic pain, anxiety, depression or are in palliative care (Source: IMS quintiles).
Martha Edith Oyuela, Khiron Health Vice President, commented, “International studies in medical cannabis use among seniors, such as the one undertaken by the University of Colorado, along with our own research, affirm the potential of addressing the seniors’ market as part of our strategy to focus on the patient community in Latin America. This relationship with CAGG increases our ability to deepen interactions with health professionals in the field and to educate on the potential benefits of prescribing medical cannabis to patients.”
Javier Cabrera Guerra, President, Colombian Association of Gerontology and Geriatrics, commented, “As valuable global research into the potential benefits of medical cannabis for seniors’ care grows, Khiron’s medical cannabis leadership and expertise will play an important role in increasing treatment awareness among our members and the wider medical community in Colombia.”
SOURCE Khiron Life Sciences Corp.
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth